Pacira BioSciences, Inc. Class Action: The Gross Law Firm Reminds Pacira Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025 - PCRX
Portfolio Pulse from
The Gross Law Firm has issued a notice to shareholders of Pacira BioSciences, Inc. (NASDAQ: PCRX) regarding a pending class action lawsuit. Shareholders who purchased shares during the specified class period are encouraged to contact the firm for potential lead plaintiff appointment. The deadline for this is March 14, 2025.
March 13, 2025 | 10:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Pacira BioSciences is facing a class action lawsuit, with a lead plaintiff deadline set for March 14, 2025. Shareholders are encouraged to contact The Gross Law Firm.
The announcement of a class action lawsuit typically has a negative impact on a company's stock price due to potential legal liabilities and associated costs. The high relevance and importance are due to the direct involvement of Pacira BioSciences in the lawsuit.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100